PCMA Statement on House Drug Pricing Legislation
September 19, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the House Democrats...
HHS Office of Inspector General Report Shows Rebates Reduced Medicare Part D Drug Spending
September 13, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health...
PCMA Welcomes New Staff Members
August 15, 2019
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing new staff additions to the Federal Affairs, State Affairs, Strategic...
OUR NEXT CONFERENCE
PCMA Annual Meeting
September 23 & 24, 2019
Scottsdale, AZ
Join us for the industry’s premier executive conference. The event is tailored specifically for senior executives from PBMs and their affiliated business partners – most notable drug manufacturers.
Learn MoreABOUT OUR INDUSTRY
PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.